Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ThermoDox + Thermal Ablation for mCRC Liver Lesions
NCT01464593Phase 2Terminated
- Sponsor
- Imunon, Inc.
- Start
- Sep 2011
- Primary completion
- May 2013
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ThermoDox in colorectal cancer (CRC), sponsored by Imunon, Inc.. Started Sep 2011; status: terminated.
02
Drugs
ThermoDox
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01464593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01464593.